2026-04-13 DoubleBlind Magazine

Psychedelic Faeries Take on Prohibition and Authoritarianism

Plus psychedelics and telepathy, ego death for the rich, and our brain on Chat GPT [...] Read More... The post Psychedelic Faeries Take on Prohibition and Authoritarianism appeared first on DoubleBlind Mag.

External link. We are not responsible for the content.

Read more ↗

More From DoubleBlind Magazine

2026-04-10 DoubleBlind Magazine

Can Psychedelics Cause Telepathy?

Here's what some of the science says. [...] Read More... The post Can Psychedelics Cause Telepathy? appeared first on...

2026-04-08 DoubleBlind Magazine

Why the Future of Psychedelics Actually Isn’t Clinical

Most psychedelic use already happens outside clinics. We should be building for that reality. [...] Read More... The ...

2026-04-06 DoubleBlind Magazine

What It Takes to Gather Now in the Psychedelic Movement

Plus, growing entheogens at home, LSD blotters, and scientology. [...] Read More... The post What It Takes to Gather ...

Latest News

2026-04-13 Psychedelic Press (Substack)

Introduction to Trip Sitting

The Art and Science of Holding Psychedelic Space

2026-04-13 Chemical Collective

Heartbreak is a Bad Trip

Oli Genn-Bash describes how the aftermath of a sudden breakup felt like a prolonged ‘bad trip’, as well as the potent...

2026-04-13 Lucid News

New Orleans Hosts Psychedelic Research Conference Double-Header

Over the last week in February, more than 200 people from psychedelic drug development companies, clinical researcher...

Research Policy
2026-04-12 The Psychedelic Blog (Substack)

Inside the Ceremony, I Could Feel the Competition

+ The Psychedelic Fit Audit

2026-04-11 Lucid News

Turning On The Culture

Author and therapist Charles Wininger asks what would happen if millions of people across the political spectrum aros...

Policy
2026-04-10 The Microdose (Berkeley)

Scientists engineered plants to produce five psychedelics at once; ‘Mega-analysis’ shows brain responses to five psychedelics share a “signature”

Plus: Texas moves forward with ibogaine trials without a drug company partner; Scientists flag risks associated with ...